Kanabo Group Plc Stock price London S.E.
Equities
SOP
GB00BYQCS703
Pharmaceuticals
Sales 2021 | 73K 92.24K | Sales 2022 | 603K 762K | Capitalization | 8.04M 10.15M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.05M | Net income 2022 | -6M -7.58M | EV / Sales 2021 | 648 x |
Net cash position 2021 | 4.5M 5.68M | Net cash position 2022 | 3.01M 3.81M | EV / Sales 2022 | 8.33 x |
P/E ratio 2021 |
-9.98
x | P/E ratio 2022 |
-1.15
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 61.92% |
Managers | Title | Age | Since |
---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | - | - |
Assaf Vardimon
DFI | Director of Finance/CFO | 46 | - |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Mattioli
CHM | Chairman | 62 | 23-05-08 |
David Tsur
BRD | Director/Board Member | 73 | 21-06-27 |
Sharon Malka
BRD | Director/Board Member | 51 | 23-05-03 |
1st Jan change | Capi. | |
---|---|---|
+35.38% | 701B | |
+26.24% | 571B | |
+1.28% | 381B | |
+20.71% | 334B | |
+16.84% | 319B | |
+1.17% | 210B | |
+2.66% | 210B | |
-6.16% | 201B | |
-3.07% | 157B |